Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_assertion type Assertion NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_head.
- NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_assertion description "[In contrast, CTGF in patients with poor prognosis (P = 0.021), metastasis (P = 0.012), local recurrence (P = 0.0024) and mortality (P = 0.0072) had markedly reduced levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_provenance.
- NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_assertion evidence source_evidence_literature NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_provenance.
- NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_assertion SIO_000772 15613452 NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_provenance.
- NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_assertion wasDerivedFrom befree-20140225 NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_provenance.
- NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_assertion wasGeneratedBy ECO_0000203 NP496154.RAqyxsF7K42VioSkCHL3nqWMnJ7CNQ2ilpfqxQLpDGwSw130_provenance.